Kenvue Rated Zacks #2 with 16.6 P/E and 3.23 P/B, Outpacing Procter & Gamble
Kenvue holds a Zacks Rank #2 (Buy) with a forward P/E of 16.63 and PEG of 4.16 compared with Procter & Gamble’s Rank #3, forward P/E 22.90 and PEG 5.34. Kenvue’s P/B of 3.23 and Value grade B outperform P&G’s P/B of 7.06 and grade C.
1. Valuation Metrics Comparison
Kenvue carries a Zacks Rank #2 (Buy), driven by stronger earnings estimate revisions, versus Procter & Gamble’s Rank #3 (Hold). Kenvue reports a forward P/E of 16.63 and PEG ratio of 4.16 alongside a P/B ratio of 3.23, compared with P&G’s forward P/E of 22.90, PEG of 5.34, and P/B of 7.06.
2. Value Grade and Investment Outlook
These metrics secure Kenvue a Value grade of B, outperforming P&G’s C grade and indicating relative undervaluation. Value investors may view Kenvue’s combination of solid analyst outlook and attractive valuation multiples as a more compelling entry point than Procter & Gamble.